{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:02:18Z","timestamp":1791597738886,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.ppat.1008590","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000}}],"reference-count":91,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA232616"],"award-info":[{"award-number":["R01 CA232616"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI147060"],"award-info":[{"award-number":["R01 AI147060"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 P01 CA022443-42"],"award-info":[{"award-number":["5 P01 CA022443-42"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 P30 CA014520-45"],"award-info":[{"award-number":["5 P30 CA014520-45"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008590","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T13:32:32Z","timestamp":1592227952000},"page":"e1008590","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-8461","authenticated-orcid":true,"given":"Chunrong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-0568","authenticated-orcid":true,"given":"James C.","family":"Romero-Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-1688","authenticated-orcid":true,"given":"Shane","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian A.","family":"Bristol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-1355","authenticated-orcid":true,"given":"Scott E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Eichelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Van Sciver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-9327","authenticated-orcid":true,"given":"Erik A.","family":"Ranheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-9189","authenticated-orcid":true,"given":"Rona S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-6526","authenticated-orcid":true,"given":"Shannon C.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"ppat.1008590.ref001","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajcp\/aqx134","article-title":"Epstein-Barr Virus-Positive Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue in the Posttransplant Setting: An Immunodeficiency-Related (Posttransplant) Lymphoproliferative Disorder?","volume":"149","author":"DP Cassidy","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"ppat.1008590.ref002","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1182\/blood-2014-11-599951","article-title":"The tumor virus landscape of AIDS-related lymphomas","volume":"125","author":"A Arvey","year":"2015","journal-title":"Blood"},{"key":"ppat.1008590.ref003","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fmicb.2013.00311","article-title":"Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection","volume":"4","author":"MR Petrara","year":"2013","journal-title":"Front Microbiol"},{"key":"ppat.1008590.ref004","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.cco.0000432525.70099.a4","article-title":"Pathology of lymphoma in HIV","volume":"25","author":"E. Cesarman","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"ppat.1008590.ref005","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1182\/blood-2010-10-310995","article-title":"A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma","volume":"117","author":"L Giulino","year":"2011","journal-title":"Blood"},{"key":"ppat.1008590.ref006","first-page":"151","article-title":"EBV Persistence\u2014Introducing the Virus","volume":"390","author":"DA Thorley-Lawson","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"ppat.1008590.ref007","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coviro.2015.09.007","article-title":"Epstein-Barr virus latency: current and future perspectives","volume":"14","author":"B Kempkes","year":"2015","journal-title":"Curr Opin Virol"},{"key":"ppat.1008590.ref008","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990\u20132010","volume":"9","author":"G Khan","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"ppat.1008590.ref009","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JVI.75.6.2929-2937.2001","article-title":"Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors","volume":"75","author":"H Chen","year":"2001","journal-title":"J Virol"},{"key":"ppat.1008590.ref010","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.00097-09","article-title":"The LMP1 promoter can be transactivated directly by NF-kappaB","volume":"83","author":"C Demetriades","year":"2009","journal-title":"J Virol"},{"key":"ppat.1008590.ref011","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1073\/pnas.0912920107","article-title":"IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter","volume":"107","author":"LL Kis","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref012","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"R K\u00fcppers","year":"2012","journal-title":"J Clin Invest"},{"key":"ppat.1008590.ref013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminhematol.2016.05.007","article-title":"Hodgkin lymphoma: Pathology and biology","volume":"53","author":"S Mathas","year":"2016","journal-title":"Semin Hematol"},{"key":"ppat.1008590.ref014","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"C Mancao","year":"2007","journal-title":"Blood"},{"key":"ppat.1008590.ref015","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"C Mancao","year":"2005","journal-title":"Blood"},{"key":"ppat.1008590.ref016","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood-2003-04-1018","article-title":"Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma","volume":"102","author":"T Portis","year":"2003","journal-title":"Blood"},{"key":"ppat.1008590.ref017","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1073\/pnas.1701836114","article-title":"Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease","volume":"114","author":"T Minamitani","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref018","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein\u2013Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells","volume":"103","author":"GL Kelly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref019","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1128\/JVI.03003-12","article-title":"Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature","volume":"87","author":"GL Kelly","year":"2013","journal-title":"J Virol"},{"key":"ppat.1008590.ref020","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2010-05-285791","article-title":"Lymphomas differ in their dependence on Epstein-Barr virus","volume":"117","author":"DT Vereide","year":"2011","journal-title":"Blood"},{"key":"ppat.1008590.ref021","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","article-title":"Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt\u2019s lymphoma cells and with increased resistance to apoptosis","volume":"79","author":"GL Kelly","year":"2005","journal-title":"J Virol"},{"key":"ppat.1008590.ref022","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JVI.01616-09","article-title":"Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1","volume":"84","author":"A Watanabe","year":"2010","journal-title":"J Virol"},{"key":"ppat.1008590.ref023","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/onc.2013.71","article-title":"Epstein-Barr virus maintains lymphomas via its miRNAs","volume":"33","author":"DT Vereide","year":"2014","journal-title":"Oncogene"},{"key":"ppat.1008590.ref024","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/ijc.30473","article-title":"The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis","volume":"140","author":"A Carbone","year":"2017","journal-title":"Int J Cancer"},{"key":"ppat.1008590.ref025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2015.06.002","article-title":"Microenvironment and HIV-related lymphomagenesis","volume":"34","author":"L Pantanowitz","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"ppat.1008590.ref026","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2013-03-488171","article-title":"The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies","volume":"122","author":"K Liapis","year":"2013","journal-title":"Blood"},{"key":"ppat.1008590.ref027","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2015-11-681411","article-title":"A lymphomagenic role for HIV beyond immune suppression","volume":"127","author":"R Dolcetti","year":"2016","journal-title":"Blood"},{"key":"ppat.1008590.ref028","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.05607-11","article-title":"Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection","volume":"85","author":"A Haas","year":"2011","journal-title":"J Virol"},{"key":"ppat.1008590.ref029","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","article-title":"Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome","volume":"113","author":"B Chetaille","year":"2009","journal-title":"Blood"},{"key":"ppat.1008590.ref030","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1038\/onc.2014.403","article-title":"The tumor microenvironment shapes hallmarks of mature B-cell malignancies","volume":"34","author":"KH Shain","year":"2015","journal-title":"Oncogene"},{"key":"ppat.1008590.ref031","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcancer.2013.07.002","article-title":"The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component","volume":"24","author":"Y Liu","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"ppat.1008590.ref032","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3324\/haematol.2015.132761","article-title":"The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints","volume":"101","author":"S Vardhana","year":"2016","journal-title":"Haematologica"},{"key":"ppat.1008590.ref033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1189\/jlb.3MR0315-136R","article-title":"The role of T cells in the microenvironment of Hodgkin lymphoma","volume":"99","author":"F Wein","year":"2016","journal-title":"J Leukoc Biol"},{"key":"ppat.1008590.ref034","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1365-2141.2002.03894.x","article-title":"An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin\u2019s lymphoma-derived cell line L591","volume":"119","author":"M Vockerodt","year":"2002","journal-title":"Br J Haematol"},{"key":"ppat.1008590.ref035","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood-2007-01-066100","article-title":"Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma","volume":"110","author":"MK Gandhi","year":"2007","journal-title":"Blood"},{"key":"ppat.1008590.ref036","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1073\/pnas.0706017104","article-title":"The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma","volume":"104","author":"P Juszczynski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref037","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","article-title":"High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin\u2019s lymphoma","volume":"154","author":"A van den Berg","year":"1999","journal-title":"Am J Pathol"},{"key":"ppat.1008590.ref038","first-page":"1270","article-title":"Macrophage-derived chemokine expression in classical Hodgkin\u2019s lymphoma: application of tissue microarrays","volume":"14","author":"CV Hedvat","year":"2001","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"ppat.1008590.ref039","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.78.4.1665-1674.2004","article-title":"Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus","volume":"78","author":"T Nakayama","year":"2004","journal-title":"J Virol"},{"key":"ppat.1008590.ref040","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2010-11-320481","article-title":"Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders","volume":"117","author":"J Ouyang","year":"2011","journal-title":"Blood"},{"key":"ppat.1008590.ref041","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1182\/blood-2013-11-534123","article-title":"Activated DDR1 increases RS cell survival","volume":"122","author":"A Carbone","year":"2013","journal-title":"Blood"},{"key":"ppat.1008590.ref042","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1182\/blood-2013-04-499004","article-title":"The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1","volume":"122","author":"FZ Cader","year":"2013","journal-title":"Blood"},{"key":"ppat.1008590.ref043","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1172\/JCI76357","article-title":"LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis","volume":"125","author":"S-D Ma","year":"2015","journal-title":"J Clin Invest"},{"key":"ppat.1008590.ref044","doi-asserted-by":"crossref","first-page":"e1007221","DOI":"10.1371\/journal.ppat.1007221","article-title":"An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model","volume":"14","author":"JC Romero-Masters","year":"2018","journal-title":"PLOS Pathog"},{"key":"ppat.1008590.ref045","article-title":"Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential","volume":"91","author":"S-D Ma","year":"2017","journal-title":"J Virol"},{"key":"ppat.1008590.ref046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002164","article-title":"C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7","volume":"7","author":"L Cancian","year":"2011","journal-title":"PLoS Pathog"},{"key":"ppat.1008590.ref047","doi-asserted-by":"crossref","first-page":"e1008365","DOI":"10.1371\/journal.ppat.1008365","article-title":"B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1\/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection","volume":"16","author":"JC Romero-Masters","year":"2020","journal-title":"PLoS Pathog"},{"key":"ppat.1008590.ref048","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","article-title":"Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation","volume":"86","author":"JI Cohen","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref049","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jviromet.2016.12.007","article-title":"Verkuijlen S a. WM, Novali\u0107 Z, Juwana H, Middeldorp JM. Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells","volume":"241","author":"AE Greijer","year":"2017","journal-title":"J Virol Methods"},{"key":"ppat.1008590.ref050","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood-2004-10-4008","article-title":"Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma","volume":"105","author":"C Renn\u00e9","year":"2005","journal-title":"Blood"},{"key":"ppat.1008590.ref051","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prp.2008.07.007","article-title":"Histological expression of angiogenic factors: VEGF, PDGFR\u03b1, and HIF-1\u03b1 in Hodgkin lymphoma","volume":"205","author":"FH Passam","year":"2009","journal-title":"Pathol\u2014Res Pract"},{"key":"ppat.1008590.ref052","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Y Huang","year":"2010","journal-title":"Blood"},{"key":"ppat.1008590.ref053","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/0008-5472.CAN-12-3849","article-title":"Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression","volume":"73","author":"WT Ho","year":"2013","journal-title":"Cancer Res"},{"key":"ppat.1008590.ref054","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1080\/10428194.2019.1607330","article-title":"Epstein-Barr virus-encoded LMP1 induces ectopic CD137 expression on Hodgkin and Reed-Sternberg cells via the PI3K-AKT-mTOR pathway","volume":"60","author":"SP Aravinth","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"ppat.1008590.ref055","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/JVI.01822-06","article-title":"EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin\u2019s lymphoma cells","volume":"81","author":"F Boccellato","year":"2007","journal-title":"J Virol"},{"key":"ppat.1008590.ref056","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/JVI.64.3.1002-1013.1990","article-title":"Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23","volume":"64","author":"M Cordier","year":"1990","journal-title":"J Virol"},{"key":"ppat.1008590.ref057","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1182\/blood-2006-05-021303","article-title":"Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth","volume":"108","author":"S Tobollik","year":"2006","journal-title":"Blood"},{"key":"ppat.1008590.ref058","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/j.1460-2075.1996.tb00367.x","article-title":"Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt\u2019s lymphoma cells","volume":"15","author":"N Jochner","year":"1996","journal-title":"EMBO J"},{"key":"ppat.1008590.ref059","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2014-08-594176","article-title":"LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates","volume":"125","author":"V Lajoie","year":"2015","journal-title":"Blood"},{"key":"ppat.1008590.ref060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(91)90893-G","article-title":"Early events in Epstein-Barr virus infection of human B lymphocytes","volume":"181","author":"C Alfieri","year":"1991","journal-title":"Virology"},{"key":"ppat.1008590.ref061","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.87.5.1725","article-title":"Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes","volume":"87","author":"M Woisetschlaeger","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref062","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1073\/pnas.88.9.3942","article-title":"Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection","volume":"88","author":"M Woisetschlaeger","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref063","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1128\/JVI.02244-06","article-title":"Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication","volume":"81","author":"L Xing","year":"2007","journal-title":"J Virol"},{"key":"ppat.1008590.ref064","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/JVI.69.1.253-262.1995","article-title":"Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1","volume":"69","author":"E Johannsen","year":"1995","journal-title":"J Virol"},{"issue":"Pt 11","key":"ppat.1008590.ref065","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1099\/0022-1317-76-11-2669","article-title":"Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters","volume":"76","author":"A Sj\u00f6blom","year":"1995","journal-title":"J Gen Virol"},{"key":"ppat.1008590.ref066","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1128\/JVI.65.12.6765-6771.1991","article-title":"Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression","volume":"65","author":"SF Tsang","year":"1991","journal-title":"J Virol"},{"key":"ppat.1008590.ref067","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/JVI.64.7.3407-3416.1990","article-title":"Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1","volume":"64","author":"F Wang","year":"1990","journal-title":"J Virol"},{"key":"ppat.1008590.ref068","doi-asserted-by":"crossref","first-page":"10468","DOI":"10.1128\/JVI.74.22.10468-10479.2000","article-title":"Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation","volume":"74","author":"RJ Tierney","year":"2000","journal-title":"J Virol"},{"key":"ppat.1008590.ref069","doi-asserted-by":"crossref","first-page":"e1000951","DOI":"10.1371\/journal.ppat.1000951","article-title":"Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP","volume":"6","author":"L Skalska","year":"2010","journal-title":"PLoS Pathog"},{"key":"ppat.1008590.ref070","first-page":"92","article-title":"Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300","author":"C Wang","year":"2018","journal-title":"J Virol"},{"key":"ppat.1008590.ref071","doi-asserted-by":"crossref","first-page":"e1006890","DOI":"10.1371\/journal.ppat.1006890","article-title":"Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming na\u00efve B cells, and facilitates recruitment of transcription factors to the viral genome","volume":"14","author":"A Szymula","year":"2018","journal-title":"PLoS Pathog"},{"key":"ppat.1008590.ref072","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/JVI.65.12.6826-6837.1991","article-title":"The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation","volume":"65","author":"JB Mannick","year":"1991","journal-title":"J Virol"},{"key":"ppat.1008590.ref073","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.93.19.10411","article-title":"c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1","volume":"93","author":"A Polack","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref074","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.20160120","article-title":"Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells","volume":"213","author":"JS Kalchschmidt","year":"2016","journal-title":"J Exp Med"},{"key":"ppat.1008590.ref075","doi-asserted-by":"crossref","first-page":"10092","DOI":"10.1128\/JVI.00358-07","article-title":"Epstein-Barr virus exploits BSAP\/Pax5 to achieve the B-cell specificity of its growth-transforming program","volume":"81","author":"R Tierney","year":"2007","journal-title":"J Virol"},{"issue":"Pt 2","key":"ppat.1008590.ref076","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/0022-1317-77-2-227","article-title":"Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines","volume":"77","author":"B Kempkes","year":"1996","journal-title":"J Gen Virol"},{"key":"ppat.1008590.ref077","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.85.24.9801","article-title":"Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency","volume":"85","author":"C Rooney","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref078","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/infdis\/168.6.1349","article-title":"Human oropharyngeal lesions with a defective Epstein-Barr virus that disrupts viral latency","volume":"168","author":"YJ Gan","year":"1993","journal-title":"J Infect Dis"},{"key":"ppat.1008590.ref079","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0002-9440(10)64900-0","article-title":"A Defective, Rearranged Epstein-Barr Virus Genome in EBER-Negative and EBER-Positive Hodgkin\u2019s Disease","volume":"160","author":"Y-J Gan","year":"2002","journal-title":"Am J Pathol"},{"key":"ppat.1008590.ref080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9440(10)63662-0","article-title":"Rearranged Epstein-Barr Virus Genome in Hodgkin\u2019s Disease and Angioimmunoblastic Lymphadenopathy: Swiss Results","volume":"163","author":"H Knecht","year":"2003","journal-title":"Am J Pathol"},{"key":"ppat.1008590.ref081","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/295160a0","article-title":"New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma","volume":"295","author":"L Heston","year":"1982","journal-title":"Nature"},{"key":"ppat.1008590.ref082","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chom.2013.11.009","article-title":"Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition","volume":"14","author":"Y-F Chiu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ppat.1008590.ref083","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"HJ Delecluse","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1008590.ref084","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas","volume":"85","author":"S-D Ma","year":"2011","journal-title":"J Virol"},{"key":"ppat.1008590.ref085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/272629a0","article-title":"A new tumour-derived transforming strain of Epstein-Barr virus","volume":"272","author":"PA Pizzo","year":"1978","journal-title":"Nature"},{"key":"ppat.1008590.ref086","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.molimm.2009.05.024","article-title":"CCAAT\/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter","volume":"46","author":"JA Bristol","year":"2009","journal-title":"Mol Immunol"},{"key":"ppat.1008590.ref087","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Y Liao","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ppat.1008590.ref088","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"MD Robinson","year":"2010","journal-title":"Genome Biol"},{"key":"ppat.1008590.ref089","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ppat.1008590.ref090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"VK Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"ppat.1008590.ref091","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinforma Oxf Engl"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008590","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008590","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T14:06:12Z","timestamp":1593093972000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008590"}},"subtitle":[],"editor":[{"given":"Kenneth M.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":91,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008590","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}